AVNTAvient Corporation

Basic Materials

$41.01+35% 1Y

$41.01

$26.8252 weeks$46.35

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though at the top of its own P/E range.

1 to watch, 1 neutral, 1 without data

What the price assumes~+5% a year

Priced for ~5% a year FCF growth. Moderate growth expectations are priced in.

Vs its own P/E rangedearer than 75% of its own historyderived

Expensive vs its own history: P/E 22.2 vs a 16.8 median over 36 quarters (+32% vs median).

Vs sector (EV/EBIT)16.6×

Sector median 17.6× across 53 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market

FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What AVNT's price assumes

Avient Corporation trades at 22.2× earnings against 31.1× for the median Specialty Chemicals name, cheaper than its own group.

22.2

Trailing P/E · Specialty Chemicals median 31.1 · cheaper than the typical name in its group

Price / sales: 1.13
Price / sales · today's price, trailing year to Jun 30, 2026
Free cash flow yield: 5.1%
Free cash flow yield · Specialty Chemicals median 4.8%
Growth the price implies: +5.5%
Growth the price implies · The price pays for +5.5% free cash flow growth a year for a decade; the business has delivered +8.5% a year over the last three.

Details›

Price / booktoday's price, trailing year to Jun 30, 2026: 1.54
EV / EBITtoday's price, trailing year to Jun 30, 2026: 16.6
EV / salestoday's price, trailing year to Jun 30, 2026: 1.56
Basic Materials median P/E202 names: 20.6
Specialty Chemicals median P/E43 names: 31.1
Free cash flow, trailing twelve months: $191M
Market capitalisation91.7 million shares, counted Jun 30, 2026: $3.76B
3-year revenue growth: +0.48%
3-year free cash flow growth: +8.5%

What the market has paid for these earnings: 36 quarters of its own multiple × $1.85 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$23.97
Its own P/E history, median	$30.99
Its own P/E history, upper quartile	$40.75
52-week range	$26.82 – $46.35
Today	$41.01

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.